The Multifaceted Roles of the Hippo-Yes-Associated Protein (YAP)/Transcriptional Coactivator with a PDZ-Binding Motif

Zihao Sui1, Ting Wang1, Chunling Yi2

  • 1Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D.C. 20057, USA.

Insights

The Hippo-Yes-associated protein (YAP)/transcriptional coactivator with a PDZ-binding motif (TAZ) pathway significantly impacts the tumor microenvironment. This pathway orchestrates immune cells, fibroblasts, and vasculature, offering a potential therapeutic target in cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • The Hippo-Yes-associated protein (YAP)/transcriptional coactivator with a PDZ-binding motif (TAZ) pathway is frequently dysregulated in various cancers.
  • This pathway's influence extends beyond tumor cells to modulate the tumor microenvironment (TME).

Purpose of the Study:

  • To review recent advances in understanding how the Hippo-YAP/TAZ pathway influences the TME.
  • To explore its roles in shaping tumor immunity, cancer-associated fibroblasts (CAFs), and tumor vasculature.

Main Methods:

  • Literature review of recent studies on Hippo-YAP/TAZ signaling in cancer.
  • Analysis of pathway's regulation of cytokines, chemokines, immune checkpoints, fibroblast activation, and angiogenesis.

Main Results:

  • Hippo-YAP/TAZ signaling regulates immune cell infiltration and function by controlling cytokine and chemokine expression.
  • YAP/TAZ drives fibroblast activation, leading to matrix stiffening and promoting cancer-associated fibrosis.
  • The pathway exhibits reciprocal regulation with vascular endothelial growth factor (VEGF), influencing tumor angiogenesis.

Conclusions:

  • The Hippo-YAP/TAZ axis is a critical regulator of the immune, stromal, and vascular components of the TME.
  • Targeting the Hippo-YAP/TAZ pathway presents a promising therapeutic strategy for cancer treatment.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...